Related Experiment Video
Updated: Jun 16, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Polymorphisms in IL4 and iLARA confer susceptibility to asthma
A A Amirzargar1, M Movahedi, N Rezaei
1Immunogenetic Laboratory, Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Journal of Investigational Allergology & Clinical Immunology
|February 5, 2010
Summary
Genetic variants in the interleukin-4 (IL-4) gene promoter are strongly associated with asthma in Iranian patients. These IL-4 gene polymorphisms and their haplotypes correlate with higher total serum immunoglobulin E (IgE) levels.
Area of Science:
- Immunogenetics
- Molecular biology
- Respiratory medicine
Background:
- Asthma is a complex respiratory disease influenced by genetic and environmental factors.
- Interleukin-4 (IL-4) production, affecting mast cell signaling, may be modulated by genetic variants in its promoter region.
- Investigating these genetic factors is crucial for understanding asthma pathogenesis.
Purpose of the Study:
- To examine the association between promoter polymorphisms of the IL-4 and IL-4 receptor alpha (IL-4RA) genes and asthma in an Iranian population.
- To identify specific genetic markers linked to asthma susceptibility and severity.
Main Methods:
- Utilized polymerase chain reaction with sequence-specific primers to analyze allele and genotype frequencies.
- Studied 59 Iranian asthma patients and 139 healthy controls.
- Investigated polymorphisms in the IL-4 and IL-4RA genes.
Main Results:
- Identified specific frequent genotypes (e.g., IL-4TC at -590) and less frequent genotypes (e.g., IL-4 CC at -590) in asthma patients compared to controls.
- Determined common IL-4 haplotypes (TCT and GTC) in the patient group.
- Observed significantly higher mean total serum IgE levels (258.8 IU/mL) in patients with the IL-4 TTT/GCC genotype compared to others (95.4 IU/mL).
Conclusions:
- Demonstrated a strong association between IL-4 gene promoter polymorphisms at -590, -33, and -1098 positions and bronchial asthma.
- Confirmed a link between specific IL-4 haplotypes and elevated serum total IgE levels.
- Suggests these genetic variations are significant factors in asthma development and IgE regulation.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.